Premium
Opportunities for collaboration between pharmacists and clinical pharmacologists to support medicines optimisation in the UK
Author(s) -
Barnett Nina L.
Publication year - 2019
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.13966
Subject(s) - formulary , medicine , pharmacy , workforce , clinical pharmacy , chemist , service (business) , alternative medicine , health care , medication therapy management , clinical pharmacology , medical prescription , nursing , family medicine , pharmacist , business , pharmacology , physics , pathology , quantum mechanics , marketing , economics , economic growth
Medicines optimisation is a clinician‐driven, person‐centred ongoing process. Pharmacists and clinical pharmacologists have medicines‐related expertise to deliver medication review which optimises clinical and cost‐effective use of medication, aligned with patient preferences, contributing to improved health outcomes. There is a large pharmacy workforce, directly accessible to patients, who can provide expert medicines‐related care on the high street, and increasingly in general practice and care homes settings. There are a small number of clinical pharmacologists in practice, mainly working in a hospital setting. Potential opportunities for collaboration are extensive, including local initiatives in collaborative education, formulary/medicines management, electronic prescribing, service evaluation, research, direct clinical services as well as strategic planning through the Regional Medicines Optimisation Committees. Pharmacists and clinical pharmacologists have complementary skill sets and through acknowledging the differences in their approaches and valuing their unique skills, health services can ensure that patients are signposted to appropriate services.